BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
48 hedge funds and large institutions have $20.4M invested in BRAINSTORM CELL THERAPUTC in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
21% less call options, than puts
Call options by funds: $1.08M | Put options by funds: $1.37M
Holders
48
Holding in Top 10
–
Calls
$1.08M
Puts
$1.37M
Top Buyers
| 1 | +$4.82M | |
| 2 | +$1.18M | |
| 3 | +$976K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$569K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$481K |
Top Sellers
| 1 | -$158K | |
| 2 | -$139K | |
| 3 | -$100K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$61.6K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$38.6K |